Dubai Investments PJSC

Logotype for Dubai Investments PJSC
Ticker/ISIN
DIC
AED000601016
Market/Country
Dubai Financial Market
United Arab Emirates

About Dubai Investments PJSC


Country of Origin: United Arab Emirates (U.A.E)

Dubai Investments PJSC (“the Company”) is a Public Joint Stock Company incorporated in the Emirate of Dubai - United Arab Emirates by Ministerial Resolution No. 46 of 1995, on 16th July 1995. The Company’s shares are listed in the Dubai Financial Market since the year 2000. Dubai Investments is a multi-asset investment Group, managing a diverse portfolio of businesses, generating sustainable financial returns to its shareholders. 

The Company and its subsidiaries (collectively referred to as “the Group”) consists of wholly and partly owned companies and the Group’s interest and investments reflect the Company’s continued focus on business diversification to drive growth.

The Group applies insight and experience to expand and be a reliable growth driver for businesses within sectors like real estate, building materials, construction & contracting, financial services, healthcare and education among others.

Latest Pressrelease Summaries from Dubai Investments PJSC

Dubai Investments announced an 18% cash dividend, totaling AED 765.36 million, for the financial year ending December 31, 2024, which was approved at the 29th Annual General Meeting on April 16, 2025. The company reported a net profit before tax of AED 1.3 billion for 2024, a 21% increase from the previous year, reflecting its strategic growth and operational excellence. The AGM also approved a new Dividend Distribution Policy. Dubai Investments, established in 1995, is a UAE-based multi-asset investment group with a diverse portfolio in sectors such as real estate, manufacturing, and healthcare, and aims to generate sustainable financial returns and drive growth through strategic investments.
Globalpharma, a leading pharmaceutical manufacturer in the UAE and a subsidiary of Dubai Investments PJSC, has partnered with India's ZIM Laboratories to introduce EU-certified Oral Dispersible Film (ODF) technology to its product range. This technology, which meets high international quality and safety standards, was announced at the AIM Congress 2025 in Dubai. The collaboration aims to enhance the UAE's role in global pharmaceutical innovation and improve healthcare solutions. The agreement was signed by key representatives from both companies and witnessed by notable officials. Globalpharma's leaders highlighted the UAE's growing influence in pharmaceutical manufacturing and discussed industry trends at the congress. The partnership with ZIM Labs is seen as a significant step in advancing patient-centric treatment options and strengthening the region's pharmaceutical capabilities. ODFs are thin, fast-dissolving strips that improve medication compliance, especially for children, the elderly, and those with swallowing difficulties. Globalpharma plans to produce these innovative treatments locally, setting a new standard for pharmaceutical manufacturing in the region.
The disclosure clarifies the process for shareholders to delegate someone to attend the General Assembly on their behalf. Shareholders can delegate individuals who are not board members, company staff, or employees of a securities brokerage company. The delegated person can represent multiple shareholders but cannot exceed 5% of the company's issued capital. Legal representatives must represent those lacking legal capacity. The shareholder's signature on the power of attorney must be approved by specific entities such as a Notary Public, Chamber of Commerce, a bank where the shareholder has an account, licensed financial markets, or any licensed notarial entity in the UAE. The proxy form should include the shareholder's name, contact number, and the approving authority. For further inquiries, contact details are provided.
Dubai Investments PJSC reported a net profit before tax of AED 1.3 billion for the fiscal year ending December 31, 2024, marking a 21% increase from the previous year. The company's total income reached AED 4.66 billion, driven by strong real estate sales and increased rental income. Total assets grew to AED 22.10 billion by the end of 2024. The board proposed an 18% cash dividend for 2024, reflecting a commitment to shareholder value. The company plans to focus on growth by evaluating investment opportunities, strategic divestments, and potential IPOs to enhance market presence and shareholder value.
Dubai Investments announced that its subsidiaries, GlobalPharma and Emirates Float Glass (EFG), have signed Memorandums of Understanding (MOUs) during a meeting in Doha, Qatar, aimed at promoting industrial growth and sustainable development. The agreements, supported by the Ministry of Industry and Advanced Technology, involve collaboration with various regional partners. GlobalPharma signed an MOU with Morocco's Zenith Pharma to enhance pharmaceutical production, focusing on critical medications, with an investment of over $50 million. Emirates Float Glass signed an MOU to supply float glass to a regional company, enhancing cooperation in the glass manufacturing sector. GlobalPharma was recognized for its contributions to pharmaceutical research and development.
Dubai Investments has announced the launch of Asayel Avenue, a new residential cluster in the Mirdif Hills development in Dubai. Asayel Avenue will feature 193 residential units, including 1, 2, and 3-bedroom apartments, designed to offer luxury, functionality, and larger living spaces with enhanced natural light. The project, with an investment of AED 400 million, is set to begin construction in Q2 2025 and complete by Q2 2027. It aims to set new standards for community-focused living in Dubai, with amenities such as fitness centers, recreational areas, and smart living solutions. The development emphasizes green integration and balanced lifestyles, catering to the demand for premium residential options in the city.
Globalpharma, a leading pharmaceutical company in the UAE and a subsidiary of Dubai Investments PJSC, plans to launch 25 new products in 2025 across therapeutic areas such as diabetes, cardiovascular, gastroenterology, and orthopaedics. This initiative is part of Globalpharma's strategy to provide high-quality and accessible medications to meet regional healthcare needs. The company aims to strengthen its distribution network and form new partnerships to ensure product accessibility and meet the needs of healthcare practitioners and patients. Globalpharma's focus for 2025 includes innovation, accessibility, and partnerships, building on the success of previous product launches in 2024. The company's efforts align with Dubai Investments' vision to transform key industries and establish a strong presence in the global pharmaceutical sector.
Dubai Investments PJSC reported a net profit after tax of AED 650.51 million for the nine-month period ending September 30, 2024, and AED 241.31 million for the three-month period ending the same date. This represents an 80% and 78% increase, respectively, compared to the previous year when adjusted for a one-off gain. The company's total assets grew to AED 21.81 billion as of September 30, 2024, from AED 21.44 billion at the end of 2023, with equity attributable to shareholders rising to AED 13.58 billion. Khalid Bin Kalban, Vice Chairman and CEO, highlighted the group's strategic focus on sustainable growth and diversification, noting strong performance in the real estate sector and investment portfolio.

Threads

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: BOD meeting

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Press release regarding financial results for the 2nd QTR of 2024

Dubai Investments reported a net profit after tax attributable to shareholders of AED 289.24 million for Q2 2024, a 78% increase from the previous year when adjusted for one-off gains. For the first half of 2024, the net profit was AED 409.20 million, an 83% increase on the same basis. The Group's total assets rose to AED 21.82 billion, while equity attributable to owners slightly decreased to AED 13.34 billion. Key highlights include the progress on the Danah Bay project, the launch of Violet Tower, and the acquisition of Carnation Education LLC by Al Mal Capital REIT. The Vice Chairman and CEO, Khalid Bin Kalban, attributed the strong performance to effective business strategies and a robust property sector. The Group remains optimistic about maintaining its performance and expanding its investment footprint.

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Financial statements for the 2nd QTR of 2024

Dubai Investments PJSC and its subsidiaries have released their condensed consolidated interim financial statements for the six-month period ending on June 30, 2024.

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Results of BOD Meeting

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: BOD meeting

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Press release regarding appointment of Liquidity Provider

Dubai Investments PJSC (DFM:DIC) has appointed xCube, a fintech company and market maker, as the Liquidity Provider for its shares listed on the Dubai Financial Market (DFM). The one-year agreement allows xCube to independently trade Dubai Investment shares starting June 11, 2024, by entering two-way daily quotes in compliance with DFM and SCA regulations. Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, emphasized that this strategic move aims to enhance shareholder value by improving liquidity, facilitating easier trading in the short term, and promoting higher valuation in the long term. Saad Chalabi, CEO of xCube, expressed gratitude for the trust placed in them and highlighted their goal to optimize liquidity, reduce bid-ask spreads, and decrease unwanted liquidity-driven volatility. Dubai Investments, established in 1995, is one of the largest investment companies in the UAE, managing a diverse portfolio across various sectors.

1. Attached Document

BondSharesBond profile image

BondSharesBond

Commented on CashwariyaRais Transaction regarding Dubai Investments PJSC

Intriguing move with Dubai Investments, CashwariyaRai. Diversification across sectors is a tactical play. Keep an eye on the Communication Services, it might just be the ace in your portfolio. Stay sharp.
TradevesterStallone profile image

TradevesterStallone

Commented on AkSharesKumars Transaction regarding Dubai Investments PJSC

Hey, buying Dubai Investments, huh? Bold move! Industrials and Financials are lookin' strong. Keep punchin' through those market swings! 🥊💪 #StayStrong
Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Press release regarding financial results for the 1st QTR of 2024

Dubai Investments, a leading diversified investment company listed on the Dubai Financial Market, reported a net profit of AED 119.96 million for Q1 2024, a decrease from AED 314.44 million in the same period in 2023. However, excluding a one-off gain from investment properties in 2023, the profit for Q1 2024 represents a 90% surge. The growth was largely due to the property sector's performance and contributions from the investment portfolio. The total income for the period was AED 791.88 million, compared to AED 1.01 billion in Q1 2023, with total assets stable at AED 21.46 billion. The company anticipates continued positive momentum throughout 2024, driven by growth in the real estate sector.

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Financial statements for the 1st QTR of 2024

The text pertains to the condensed consolidated interim financial statements of Dubai Investments PJSC and its subsidiaries for the three-month period ending on 31 March 2024.

1. Attached Document